The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and molecular landscape of metastatic colorectal cancer (mCRC) harboring ALK, ROS1, or NTRK 1, 2, 3 (NTRKs) rearrangements.
 
Filippo Pietrantonio
No Relationships to Disclose
 
Federica Di Nicolantonio
No Relationships to Disclose
 
Alexa Betzig Schrock
Employment - Foundation Medicine
 
Jeeyun Lee
No Relationships to Disclose
 
Sabine Tejpar
Honoraria - Merck Serono; Regeneron
Consulting or Advisory Role - Bayer; Merck Serono; Regeneron
Speakers' Bureau - Merck Serono; Roche; Sanofi
Research Funding - Merck Serono (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Sanofi
 
Salvatore Siena
No Relationships to Disclose
 
Jason H. Christiansen
Employment - Ignyta
 
Jaclyn Frances Hechtman
Consulting or Advisory Role - Navigant Consulting
 
Giovanni Fucà
No Relationships to Disclose
 
Carlotta Antoniotti
No Relationships to Disclose
 
Seung Tae Kim
No Relationships to Disclose
 
Bosun Min
Employment - Ignyta
 
Danielle Murphy
Employment - Ignyta
 
Niall C. Tebbutt
No Relationships to Disclose
 
Jeffrey S. Ross
Employment - Foundation Medicine
 
Alberto Bardelli
Stock and Other Ownership Interests - Horizon Discovery
Consulting or Advisory Role - Biocartis; Horizon Discovery; Trovagene
Speakers' Bureau - Novartis
 
Siraj Mahamed Ali
Employment - Foundation Medicine
 
Alfredo Falcone
No Relationships to Disclose
 
Filippo G. De Braud
No Relationships to Disclose
 
Chiara Cremolini
No Relationships to Disclose